Jefferies Says Advanced Bionics Processor Unlikely to Disrupt Cochlear
Jefferies analyst David Stanton says Cochlear's scale, clinic relationships and recipient base should limit near-term disruption from Advanced Bionics' new Integro CI sound processor.